)
Sanket Koul is a mass communication graduate with a PG diploma in English Journalism from IIMC Delhi. As a correspondent at Business Standard, he covers the pulse of the social sector, from industry and institutional developments, to the government's latest moves in education, healthcare, pharmaceuticals and medical devices sectors.
Sanket Koul is a mass communication graduate with a PG diploma in English Journalism from IIMC Delhi. As a correspondent at Business Standard, he covers the pulse of the social sector, from industry and institutional developments, to the government's latest moves in education, healthcare, pharmaceuticals and medical devices sectors.
India's Rs 628-crore anti-obesity market sees heightened competition as Wegovy and Mounjaro post strong sales amid rising obesity and growing doctor awareness
Pharma MSMEs seek Rs 50 crore handholding and extension for GMP compliance under revised Schedule M, citing challenges in adhering to regulatory and quality standards
Highest-ever land deal figure comes on the back of increased interest in diversified asset classes
A Delhi HC directive to examine unregulated use of weight loss drugs may lead to a CDSCO expert panel by mid-July, possibly led by DCGI with pharma and govt representation
Indian students putting the American dream on hold
India's real estate sector saw a 42 per cent Y-o-Y fall in institutional investment in Q2 2025, even as foreign inflows surged 242 per cent sequentially
New NMC faculty rules allow more specialists to be appointed as professors, supporting the Union Health Ministry's push to expand medical education by 75,000 seats in five years
NIV Pune on Friday had confirmed Nipah infection in 38-year-old female from Palakkad
Office, warehousing, industrial segments drive real estate leasing momentum in first half
Space, privacy, prestige selling points for buyers
Sales of homes priced above ₹1 crore rose 17% year-on-year in H1 CY25, while affordable housing sales fell 18% due to demand and supply constraints, Knight Frank data shows
With increased US competition from FY26, DRL plans portfolio shifts, inorganic growth, cost control and global expansion to manage profit and revenue impact
Crisil report says demand will rebound in FY26 driven by premium and luxury housing across major micro markets; affordable housing launches remain limited
The carve-out will be effective from 1 July 2025, according to the company's regulatory filing on the exchanges.
Marriott to operate a 200-key Westin Hotel in Ludhiana under partnership with Oswal Group's realty arm, part of a seven-acre mixed-use commercial project
BE to produce and commercialise Recbio's nine-valent HPV vaccine in India and global markets, including participation in UNICEF and PAHO tenders
Experts indicate buyers are moving towards high-ticket-size transactions, with the city recording its second-highest property registration figures in June 2025
A recent Lancet report had grouped India among eight countries having more than half of the world's zero dose children as of 2023
Medical device companies raise issues with the DoP over UDMPMD norms related to disclosure of training expenses and restrictions on overseas training approvals
Eli Lilly's prefilled shot arrives a day after Wegovy, reloading race for expanding waistline market